Complete report $1,900. Individual company assessments $250. The companies analyzed in this report include Bayer, Boehringer Ingelheim, Ceva, Elanco, Intervet, Merial, Novartis, Pfizer, Phibro, and Virbac. For each company, the report provides: • Internally developed and acquired animal health technologies, processes and related capabilities. • Proprietary technologies and patent litigations. Contains 30 pages
|